CTOs on the Move


 
Eos is a leading beauty and skincare brand that originated around a key insight, women want products that deliver moments of delight that transcend daily routines. From its iconic lip balm to hand and body lotion to shave cream, Eos products are hypoallergenic, dermatologist-tested, gluten-free, and packed with nourishing vitamins and natural skin-conditioning oils.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Quality Medical Evaluations

Quality Medical Evaluations is a Westborough, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Technology Commercialization Group

Technology Commercialization Group is a Durham, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

MedServe

MedServe is a Bellaire, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

FutureScripts

FutureScripts is a Philadelphia, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Volition

Volition is a multi-national epigenetics company that applies its Nucleosomics™ platform through its subsidiaries to develop simple, easy to use, cost effective blood tests to help diagnose and monitor a range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. Early diagnosis and monitoring have the potential to not only prolong the life of patients but also improve their quality of life. The tests are based on the science of Nucleosomics™, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. Volition is primarily focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring. Volition`s research and development activities are centered in Belgium, with an innovation laboratory in California and additional offices in Texas, London, and Singapore, as the company focuses on bringing its diagnostic and disease monitoring products to market.